by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

R3 Medical Companies Warning Letter Details

Warning Letter

R3 Medical Companies

Recipient Name David L. Greene, M.D., R3 Medical Companies, 10045 E. Dynamite Blvd., Suite 260 Scottsdale , AZ 85262 United States

Issue DateAugust 14, 2026

FEI NumberN/A

Violations13

CountryUnited States

Issuing Office

Center for Biologics Evaluation and Research (CBER)

Product Type

Biologics

Status

Open

Subject

Unapproved New Drugs/Unlicensed Biological Product Violations

R3 Medical Companies FDA Warning Letter, August 14, 2026